Fundraising Fox

Josh Silverman

Investor

CEO and Founder of Windfall Bio at Baruch Future Ventures

Sunnyvale, California, United States

Find your path to Josh

739 people in our graph share verified history with Josh β€” schools, employers, funds. One of them is your warm intro.

Paul KwanunlockedJosh: together at Stanford University (1997–2002)
Γ—8Josh: together at Stanford University
Γ—2Josh: together at Stanford University School of Medicine
Josh: together at Amgen

About

Josh Silverman, Ph.D., is the CEO and founder of Windfall Bio, which develops nature-based technology to convert methane into organic soil nutrients. He has more than 20 years of experience in biotech research and commercialization, previously serving as CEO of Aromyx, founder and CTO of Calysta, and VP of Drug Development at Amunix, and has advised several climate-focused biotech companies. He holds a B.Sc. in Molecular Biology from UC San Diego and a Ph.D. in Biochemistry from Stanford University.

Invests in

BiotechCleantechClimate Tech

Experience

  1. Windfall BioChief Executive Officer & Foundercurrent2022 β€” presentMenlo Park, California, United States
  2. Aromyx CorporationChief Science Advisorcurrent2022 β€” present
  3. Aromyx CorporationCEO2018 β€” 2022
  4. Calysta EnergyChief Technology Officer and Co-Founder2011 β€” 2018
  5. S3 Innovations, IncPresident and Founder2010 β€” 2014
  6. Siluria Technologies, Inc.Scientific founder and phage supplier2008 β€” 2012South San Francisco, California, United States
  7. Amunix, Inc.Vice President, Product Development2008 β€” 2011
  8. AmgenDirector Process Development2006 β€” 2008
  9. Avidia Research InstituteDirector - CMC2003 β€” 2006
  10. MaxygenScientist2002 β€” 2003

Skills & more

Biotechnology29Drug Discovery12Biochemistry17Lifesciences6Protein Chemistry18Molecular Biology14Technology Transfer10Genomics4Drug Development5Cell Biology2Cell Culture3Biopharmaceuticals4
+4 moreCellBiomarkersAssay DevelopmentProtein Purification

From Josh's professional profile.

Colleagues at Baruch Future Ventures

Frequently asked questions

Who is Josh Silverman?
Josh Silverman, Ph.D., is the CEO and founder of Windfall Bio, which develops nature-based technology to convert methane into organic soil nutrients. He has more than 20 years of experience in biotech research and commercialization, previously serving as CEO of Aromyx, founder and CTO of Calysta, and VP of Drug Development at Amunix, and has advised several climate-focused biotech companies. He holds a B.Sc. in Molecular Biology from UC San Diego and a Ph.D. in Biochemistry from Stanford University.
Where does Josh Silverman work?
Josh Silverman is CEO and Founder of Windfall Bio at Baruch Future Ventures.
What does Josh Silverman invest in?
Josh Silverman invests in Biotech, Cleantech, Climate Tech.
Where did Josh Silverman go to school?
Josh Silverman studied at Stanford University School of Medicine (Doctor of Philosophy (PhD), Biochemistry); Stanford University (PhD, Biochemistry).

Founder mafias

Same school

Shared employers